Secondary Ophthalmic Features Represent Diagnostic Clues and Potential Points of Intervention for Inherited Retinal Diseases (Target 5000 Report 3)
Genes · 2025
DOI: 10.3390/genes16121433 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Kirk A J Stephenson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Mater Clinical Ophthalmic Genetics Unit, Mater Misericordiae University Hospital, D07 R2WY Dublin, Ireland. Hauptthemen laut MEDLINE: Retinal Diseases, Retinal Degeneration. Die Arbeit nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fighting Blindness, Health Research Board, Science Foundation Ireland.
Abstract (Originalsprache)
Background/Objective: Inherited retinal degenerations (IRDs) are the leading cause of blind registration in children and adults, yet 30–40% of cases remain genetically unresolved. Deep ophthalmic phenotyping may help to address this shortfall by identifying characteristic phenotypes. We describe the ophthalmic features of patients with stationary or progressive inherited retinal diseases other than outer retinal degeneration (i.e., secondary ophthalmic features, SOFs).
Methods
This is a retrospective review of all patients attending an ophthalmic genetics clinic with a genetically confirmed IRD focusing on SOFs including refractive error, cataract, retinal detachment (RRD), cystoid macular lesions (CML) and epiretinal membrane (ERM). These features were assessed in the context of phenotype and genotype.
Results
In a cohort of 429 genotyped patients, ≥1 SOFs were seen in 70.2% of patients, with 36.6% being affected by multiple SOFs. Refractive error (63.3%) and cataract (43.4%) were the most common secondary features, with a subset affected by CML (14.7%), ERM (10%) and RRD (4.7%).
Conclusions
SOFs are common in patients with IRDs and most are amenable to therapeutic intervention even when no primary treatment (e.g., gene therapy) is available. We highlight patterns associated with genotypes and disease groups which may aid harmonisation of clinical and genetic diagnoses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mater Clinical Ophthalmic Genetics Unit, Mater Misericordiae University Hospital, D07 R2WY Dublin, Ireland.
- Children's Health Ireland, D01 X584 Dublin, Ireland.
- Next Generation Sequencing Laboratory, Mater Misericordiae University Hospital, Eccles Street, D07 R2WY Dublin, Ireland.
- Smurfit Institute of Genetics, Trinity College Dublin, University of Dublin, D02 VF25 Dublin, Ireland.
- National Centre for Inherited Metabolic Disorders, Mater Misericordiae University Hospital, D07 R2WY Dublin, Ireland.
- School of Medicine, Trinity College Dublin, University of Dublin, D02 P3X2 Dublin, Ireland.
ORCID-Profile: Julia Zhu, Adrian Dockery, Laura Whelan, D Ian Flitcroft
Förderung
- Fighting Blindness
- Health Research Board
- Science Foundation Ireland
- Health Research Charities Ireland
- Fighting Blindness Ireland
- Health Research Board Ireland
Zitieren
APA
Stephenson, K. A. J., Zhu, J., Conway, M., Moran, B., Dockery, A., Whelan, L., Turner, J., O'Byrne, J. J., Flitcroft, D. I., Farrar, G. J., & Keegan, D. J. (2025). Secondary Ophthalmic Features Represent Diagnostic Clues and Potential Points of Intervention for Inherited Retinal Diseases (Target 5000 Report 3). Genes. https://doi.org/10.3390/genes16121433
Vancouver
Stephenson KAJ, Zhu J, Conway M, Moran B, Dockery A, Whelan L, et al. Secondary Ophthalmic Features Represent Diagnostic Clues and Potential Points of Intervention for Inherited Retinal Diseases (Target 5000 Report 3). Genes. 2025. doi:10.3390/genes16121433
BibTeX
@article{Stephenson2025,
author = {Stephenson, Kirk A J and Zhu, Julia and Conway, Marcus and Moran, Bridget and Dockery, Adrian and Whelan, Laura and Turner, Jacqueline and O'Byrne, James J and Flitcroft, D Ian and Farrar, G Jane and Keegan, David J},
title = {Secondary Ophthalmic Features Represent Diagnostic Clues and Potential Points of Intervention for Inherited Retinal Diseases (Target 5000 Report 3)},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16121433}
}
EUVIMED